SPOP and prostate carcinoma: Speckle type BTB/POZ protein (SPOP) mutation is the most frequent point mutation in primary prostate cancer (~10%) and has been reported as an early clonal event as well as a distinct ETS-negative molecular subclass (6, 15, 16).